Acadia Pharmaceuticals Inc

CA · United States · Reporting entity ID 100000141529

Total reported 2019–2025

$87.7M

#108 of 2,960 reporting companies — 0.1% of all reported industry payments

$21.0M in general payments across 146,706 records, plus $66.7M in research funding across 10,608 records.

How it breaks down

General payments $20,976,901

Research funding $66,688,490

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.